We show that these cancer-derived SPOP mutants fail to earmark ILF3 for poly-ubiquitination and subsequent degradation, thereby accumulating ILF3 to subsequently activate the SGOC pathway and metabolic reprogramming. This evidence concerns the gene ILF3 and cancer.